Warning letter
Morton Grove Pharmaceuticals Inc.: warning letter of Jan 14, 2000
FDA warning letter UCM068036 · Chicago District Office
Key facts
| Reference number | UCM068036 |
|---|---|
| Company | Morton Grove Pharmaceuticals Inc. |
| Subject | Drug Products / CGMP |
| Issue date | Jan 14, 2000 |
| Posted date | Jan 14, 2000 |
| Issuing office | Chicago District Office |
| Product type | Drugs |
| CFR sections cited | 211.100(b), 211.113(a), 21, 211, 211.100, 211.160, 211.192, 211.100(a) |
| Country | 3 |
| Inspection city | Morton Grove |
| Inspection ZIP | 60053-2633 |
| Inspection start date | Nov 16, 1999 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: